Manufacturing

Strategic location within the Houston biotech hub provides Bristol Myers Squibb with access to a robust ecosystem of talent, infrastructure, and academic partnerships. This massive $2.3 billion investment represents a definitive shift toward securing the domestic supply chain and modernizing the

The convergence of legacy manufacturing expertise and cutting-edge molecular platforms is fundamentally transforming the current biopharmaceutical landscape. This paradigm shift marks the end of an era defined by slow, incremental improvements and the beginning of a highly synchronized digital age.

This digital initiative addresses long-standing inefficiencies by providing a public mechanism to verify the legal status of medical devices sold throughout the country. For many years, the Mexican medical device market struggled with a lack of transparency, where paper-based records led to

Maintaining medicinal consistency across a global network requires navigating a labyrinth of geopolitical shifts and varying international regulatory expectations. The journey of a pharmaceutical product from a manufacturing plant to a patient’s local pharmacy is an intricate operation governed by

Laboratories specializing in virology and immunology must now evaluate if their current biosafety margins are sufficient to protect staff from aerosolized H5N1 exposure. The recent isolation of live, infectious H5N1 avian influenza from a commercial batch of fetal bovine serum (FBS) has sparked a

Utilizing brewery-style fermentation tanks to cultivate cocoa cells allows manufacturers to maintain 100 percent supply-chain stability regardless of unpredictable weather patterns. This innovative methodology, pioneered by Boston-based biotechnology leader GALY, arrives at a critical juncture for